In this article we will take a look at ten best performing US stocks in 2025 so far.
It’s been a rollercoaster year for the U.S. stock market, but a handful of companies are crushing expectations and delivering triple digit returns. From crypto powered disruptors to dividend dynamos, the best performing US stocks in 2025 are riding strong catalysts, and investors are taking notice. Despite rising interest rates, geopolitical tensions, and the chaos of a second Trump term, these stocks are finding ways to shine.
As of July, the MSCI All Country World Index is up nearly 10% year to date, with U.S. equities contributing significantly to that rally , reported CNBC. Among the standout performers, some stocks have surged over 2,000% since January, fueled by sector specific tailwinds, strong earnings, and investor optimism around innovation and technology.
So, what’s driving these outsized gains? A mix of bold business pivots, booming sectors, and market defying innovation. Whether it's tech companies doubling down on blockchain or traditional firms leaning into AI and new energy, these leaders have found the right formula at the right time.
Let’s set the scene: The Federal Reserve is under pressure. According to Bloomberg, traders are betting that Trump’s incoming Fed pick may push for rate cuts, but experts warn it won’t be easy. Meanwhile, Reuters reported that the Fed minutes from June show deep internal disagreements over inflation and tariffs, with uncertainty clouding the rate path ahead. Despite all this, stocks like DFDV, Nvidia, and Meta are crushing it, thanks to strong fundamentals, aggressive strategies, and investor confidence in their long term vision.
Oil prices are volatile, trade policies are shifting, and global supply chains remain tight. Yet companies that know how to execute, especially in areas like crypto, AI, and digital infrastructure, are reaping the rewards. Tariff headlines have rattled markets, Trump’s new import duties on 14 countries are set to take effect August 1, but CNBC’s Jim Cramer has suggested the market may be overreacting, calling the latest tariffs more “negotiation tools” than long term threats.
In this article, we break down the ten best performing US stocks in 2025 so far, highlighting why they are winning, what makes them special, and what risks, if any, could slow their momentum. Whether you're an investor chasing growth or a market watcher tracking trends, this list offers insight into where the real gains are happening, and why. Let’s dive in.
Our Approach to Identifying the best performing US stocks in 2025 so far
To determine the top 10 best performing US stocks in 2025 so far, we screened for companies headquartered in the United States with a market capitalization exceeding $300 million. The primary selection criterion was year to date (YTD) price return as of July 8, allowing us to spotlight the stocks that have delivered the strongest performance this year. By focusing on price appreciation, regardless of industry sector, we aimed to capture the most notable momentum plays in the current market. The final list is ranked in descending order of YTD return, offering investors a clear view of the standout performers of 2025 so far.
10 Best Performing US Stocks in 2025 So Far
10. Citius Oncology Inc (NASDAQ:CTOR) : A Biotech Breakout Among the Best Performing US Stocks in 2025
Year to date Price Return as of July 8: 270.43%
Our list of ten best performing US stocks in 2025 starts with Citius Oncology Inc (NASDAQ:CTOR). Citius Oncology Inc (NASDAQ:CTOR) is one of the biggest breakout stocks of 2025, delivering a massive year to date gain of 270.43% as of July 8. That’s far ahead of the S&P 500’s 5.85% return, showing strong investor interest and market confidence. The stock recently regained compliance with Nasdaq’s listing rules, giving investors even more reasons to stay bullish.
Citius Oncology is a U.S. based biotech company focused on cancer treatments. Its main product is LYMPHIR, a newly approved drug for treating a rare form of skin lymphoma called CTCL. The drug was approved by the FDA in August 2024, and the company is now preparing for its full commercial launch.
Financially, the company is in growth mode. It didn’t report revenue yet, but it’s investing heavily in research and marketing. In the latest quarter, R&D spending rose to $3.1 million, and general business costs increased to $2.2 million, mainly due to launch preparations for LYMPHIR. Though it posted a net loss of $7.7 million, this is common for biotech firms in early commercialization stages.
Citius also holds exclusive rights to market LYMPHIR in major global regions through deals with Eisai and Dr. Reddy’s. With the drug now approved and commercial activity picking up, Citius Oncology Inc (NASDAQ:CTOR) is well placed as a high potential biotech stock for 2025, one that growth investors should keep a close eye on.
09. CoreWeave Inc (NASDAQ:CRWV) : AI Powerhouse Leading the Charge Among Top US Stocks in 2025
Year to date Price Return as of July 8: 278.63%
CoreWeave Inc (NASDAQ:CRWV) is having a blockbuster year in 2025, with its stock soaring 278.63% year to date as of July 8. That kind of growth isn’t just luck, it reflects massive demand, serious momentum, and the company’s rapid rise as a key player in the AI infrastructure space. Its impressive surge has earned it a place among the best performing US stocks of the year.
Based in New Jersey, CoreWeave Inc (NASDAQ:CRWV) runs a specialized cloud platform built to support high performance AI workloads. From AI model training and inference to VFX rendering and massive compute power delivery, it offers the tools that fuel today’s artificial intelligence boom. Its platform includes GPU and CPU compute, object storage, networking, and proprietary software optimized for generative AI.
Financially, CoreWeave is scaling fast, and profitably. In Q1 2025, revenue hit a record $982 million, up 420% year over year, while adjusted operating income surged 550% to $163 million. The company also delivered $606 million in adjusted EBITDA, with a margin of 62%, showing strong operational efficiency.
A major growth driver: CoreWeave’s landmark $11.9 billion contract with OpenAI, signed in March, alongside a $4 billion expansion deal with another top AI enterprise. These long term contracts give the company visibility into future cash flows, with a backlog of $25.9 billion, up 63% YoY.
On top of that, CoreWeave Inc (NASDAQ:CRWV) acquisition of Weights & Biases, a popular AI developer tool with 1,400+ clients, and its purchase of Core Scientific, strengthens its position as a full stack AI infrastructure leader.
CoreWeave now operates 33 AI focused data centers and is the first cloud provider to deploy NVIDIA’s powerful GB200 Grace Blackwell systems at scale. With unmatched tech, deep enterprise demand, and smart financial strategy, CoreWeave is not just riding the AI wave, it’s building it.
08. Sezzle Inc (NASDAQ:SEZL) : Fintech Disruptor With Triple Digit Returns in the US Stock Market
Year to date Price Return as of July 8: 285.01%
At number eight on our list of ten best performing US stocks in 2025 stands Sezzle Inc (NASDAQ:SEZL). Sezzle Inc (NASDAQ:SEZL) is turning heads on Wall Street in 2025. With a 285.01% year to date return as of July 8, the stock is one of the year's biggest gainers, powered by strong fundamentals, efficient growth, and a booming fintech market.
Based in Minneapolis, Sezzle is a fintech company focused on “Buy Now, Pay Later” (BNPL) services across the U.S. and Canada. It allows consumers to break up purchases into manageable installments, like its flagship Pay in Four plan, while enabling merchants to boost sales through seamless point of sale financing. Its product suite also includes virtual cards, subscriptions like Sezzle Anywhere and Premium, and a growing long term lending business.
Sezzle Inc (NASDAQ:SEZL) Q1 2025 results prove it’s not just surviving in a competitive BNPL space, it’s thriving. Revenue jumped 123% YoY to $104.9 million, while adjusted net income soared 286% to $36.2 million. The company achieved a net income margin of 34.5% and an impressive 49% adjusted EBITDA margin, validating its high efficiency business model.
The company is also scaling fast. Gross Merchandise Volume (GMV) rose 64% YoY, and its MODS (monthly on demand subscribers) increased by 77%. This operational leverage drove a 70.4% gross margin, with revenue per GMV climbing to 13%, even in a seasonally soft quarter.
Sezzle Inc (NASDAQ:SEZL) balance sheet is strengthening too, cash from operations hit $58.8 million, and the firm initiated a $50 million stock repurchase program, reflecting confidence in future growth. It also raised 2025 guidance, with expected EPS jumping from $2.21 to $3.25.
With repeat usage, consumer engagement, and enterprise adoption all trending upward, Sezzle Inc (NASDAQ:SEZL) is proving that responsible BNPL solutions can be profitable and scalable. The stock’s breakout performance is backed by fundamentals, and it may just be getting started.
07. Vigil Neuroscience Inc (NASDAQ:VIGL) : A High Return US Stock in 2025 Fueling Biotech Innovation
Year to date Price Return as of July 8: 371.76%
Vigil Neuroscience Inc (NASDAQ:VIGL) is quietly emerging as one of biotech’s brightest stars in 2025. While many stocks wobble in uncertain markets, Vigil is gaining attention for advancing next gen treatments targeting neurodegenerative diseases like Alzheimer’s and ALSP. Its steady progress and investor optimism are making it a standout among the best performing US stocks this year.
Based in Watertown, Massachusetts, Vigil is a clinical stage biotech firm focused on microglia, specialized immune cells in the brain. Their lead drug candidate, Iluzanebart (VGL101), is in a Phase 2 trial for treating ALSP, a rare but deadly brain disease. Meanwhile, VG 3927, an oral TREM2 agonist, is targeting Alzheimer’s disease and expected to enter Phase 2 trials in Q3 2025.
What makes Vigil stand out is the pace of its clinical progress and the promising safety data. VG 3927 showed favorable results in its Phase 1 trial, including strong central nervous system penetration, predictable dosing, and robust pharmacodynamic response. No serious adverse events were reported, a significant positive for future Alzheimer’s treatment options.
Financially, Vigil Neuroscience Inc (NASDAQ:VIGL) is maintaining a solid foundation to fuel its pipeline. As of Q1 2025, the company had $87.1 million in cash and marketable securities, which is expected to fund operations into 2026. While it reported a net loss of $22.4 million, that figure aligns with early stage biotech investment cycles and reflects ramped up R&D spending, particularly for VG 3927’s development.
Investors are watching closely as Vigil nears key milestones. Final data from the Iluzanebart Phase 2 trial is due in Q2 2025, with the company eyeing an accelerated approval pathway. A Phase 2 trial for VG 3927 in Alzheimer’s is also set to begin in Q3, targeting a large unmet market.
With two high potential assets, strategic licensing from Amgen, and a focus on precision neurology, Vigil Neuroscience Inc (NASDAQ:VIGL) is making all the right moves in 2025. This under the radar biotech may not stay quiet for long.
06. Arena Group Holdings Inc (NYSE:AREN) : A Digital Media Turnaround Among the Best Performing US Stocks in 2025
Year to date Price Return as of July 8: 373.88%
Arena Group Holdings Inc (NYSE:AREN) is turning heads in 2025 with a sharp digital pivot and major turnaround in profitability. After a turbulent 2024, this media tech hybrid has delivered one of the most impressive rebounds in the digital publishing sector this year.
Headquartered in New York, Arena Group Holdings Inc (NYSE:AREN) operates a cutting edge publishing platform that powers 20+ owned media brands, including TheStreet, Parade, Men’s Journal, and The Spun, along with over 150 independent publisher partners. Its proprietary tech platform offers SEO, ad monetization, and video tools, giving it a competitive edge in today’s content economy.
In Q1 2025, Arena posted $3.99 million in net income from continuing operations, reversing a $12.7 million loss from the same period last year. This dramatic swing was driven by both higher revenue and tighter cost control. Revenue grew 9.9% YoY to $31.8 million, while cost of revenue dropped nearly 20%, improving gross profit by 75%. The company also slashed selling and administrative expenses by more than 50%.
Key digital metrics also point toward healthy growth. Monthly average pageviews rose 15%, reaching over 327 million, and RPM (revenue per 1,000 views) jumped 20% to $22.21, boosted by stronger video ad revenue.
Despite a working capital deficit, Arena Group Holdings Inc (NYSE:AREN) is actively managing liquidity through cost cutting and strategic financing. Its $87K net cash from operations and access to over $42 million in working capital loans from Simplify signal near term runway.
Arena Group Holdings Inc (NYSE:AREN) focus on premium verticals, finance, sports, and lifestyle, and scalable publishing tech gives it both breadth and depth in audience monetization. With improving margins, a leaner operation, and a strong revenue mix shift toward video, Arena Group Holdings Inc (NYSE:AREN) stock is gaining momentum as a digital media comeback story in 2025.
05. ThredUp Inc (NASDAQ:TDUP) : Sustainable Fashion Star and One of the Best Performing US Stocks of 2025
Year to date Price Return as of July 8: 398.56%
ThredUp Inc (NASDAQ:TDUP) is stealing the spotlight in 2025 with a massive YTD return of over 398%. Fueled by record breaking buyer growth, margin expansion, and a powerful AI upgrade, this secondhand fashion disruptor is turning resale into retail’s hottest rebound story. Its explosive performance has placed it firmly among the best performing US stocks this year.
Based in Oakland, California, ThredUp runs an online marketplace that lets users buy and sell secondhand apparel, shoes, and accessories. With over 4 million items listed and a growing base of 60,000+ brands, its AI powered platform is redefining how consumers shop and discover fashion.
In Q1 2025, ThredUp Inc (NASDAQ:TDUP) crushed earnings expectations, posting a smaller than expected EPS loss of $ 0.04 vs. estimates of $ 0.07, while revenue jumped 10.5% YoY to $71.3 million. Adjusted EBITDA hit $3.8 million (5.3% margin), more than double the prior year, and free cash flow reached a record $3.9 million. Buyer growth is surging, with active users up 5.7% YoY and new buyer acquisition soaring 95%, its strongest quarter ever.
Gross margin stayed robust at 79.1%, despite offering incentives to convert new users. Backed by $55.4 million in cash and a capital light model, ThredUp is investing heavily in marketing and AI innovation, including personalized product discovery and visual search. Its "Shop Social" tool, linking user style inspiration from Instagram, is already showing 4x higher conversion rates.
Risks remain, including broader macro uncertainty and potential margin pressure from ongoing buyer incentives. However, with tariffs raising prices on fast fashion competitors like Shein and Temu, ThredUp Inc (NASDAQ:TDUP) is well placed to benefit from shifting consumer trends toward sustainable and affordable alternatives.
ThredUp Inc (NASDAQ:TDUP) stock’s meteoric rise is backed by improving fundamentals, accelerating user growth, and tech driven retail disruption, making it one of the most compelling growth stories and a standout contender on our list of best performing US stocks in 2025.
04. BioSig Technologies Inc (NASDAQ:BSGM) : A Triple Digit Return Stock Transforming Health Tech in 2025
Year to date Price Return as of July 8: 463.09%
BioSig Technologies Inc (NASDAQ:BSGM) is turning heads in 2025 with its precision driven medical tech and fast growing IP portfolio. As AI and healthcare converge, BioSig stands at the frontier of innovation with a unique edge in cardiac signal processing. The company’s recent shift toward software and data analytics is powering investor confidence in its long term growth, helping it earn a spot among the best performing US stocks this year.
Headquartered in Los Angeles, BioSig Technologies Inc (NASDAQ:BSGM) is a medical device and digital health company behind the PURE EP Platform, an advanced signal processing system that helps electrophysiologists better diagnose and treat heart rhythm disorders like AFib and VT. It also holds rights through a Mayo Clinic partnership, bolstering its IP in AI, signal recording, and real time data processing.
While revenues remain modest, BioSig Technologies Inc (NASDAQ:BSGM) is laser focused on R&D and IP development. In Q1 2025, the company significantly reduced R&D costs by over 97%, reflecting its transition from hardware production to next gen software algorithms. It currently holds 41 issued patents and 30 global design patents, with AI powered features in development that aim to make pulsed field ablation (PFA) procedures more precise and effective.
Despite a net loss of $2.8 million in Q1, the company cut costs, improved cash flow through strategic financing, and raised over $4.7 million via equity offerings, a critical step toward sustaining operations and funding commercialization efforts. The working capital surplus of $2.31 million suggests improved short term liquidity, even as management acknowledges the going concern risks ahead.
Risks remain, notably ongoing losses, dilution concerns, and the need for regulatory approvals, but BioSig’s pivot toward high margin software, AI applications, and real world signal analytics could make it a dark horse in 2025’s healthtech boom.
For investors bullish on precision medicine and AI driven diagnostics, BioSig Technologies Inc (NASDAQ:BSGM) is a high risk, high reward play worth watching.
03. Aeva Technologies Inc (NASDAQ:AEVA) : LiDAR Innovator Among the Top US Stocks in 2025
Year to date Price Return as of July 8: 531.58%
Aeva Technologies Inc (NASDAQ:AEVA) hold third position in our list of best performing US stocks in 2025. Aeva Technologies Inc (NASDAQ:AEVA) has stunned Wall Street in 2025 with a year to date return of over 530%. Fueled by disruptive innovation in 4D LiDAR technology and a growing list of strategic partnerships, Aeva is quickly emerging as a top player in next gen sensing solutions. Investors are taking notice, and for good reason.
Based in Mountain View, California, Aeva Technologies Inc (NASDAQ:AEVA) designs and manufactures cutting edge LiDAR sensors using frequency modulated continuous wave (FMCW) technology. Its flagship products, including Aeries II and Atlas Ultra, deliver real time velocity and depth data for autonomous vehicles, robotics, and industrial automation. The company’s CoreVision LiDAR on chip module enables compact, high precision sensing across sectors from automotive to consumer electronics.
In Q1 2025, Aeva beat EPS expectations, reporting a narrower than expected loss of $ 0.45 per share. More importantly, it is seeing commercial traction across key verticals. Aeva secured over 1,000 unit orders for its new Eve 1 sensors, targeting the $4 billion laser displacement market. Strategic deals, such as becoming the exclusive LiDAR supplier for Sensys Gatso’s speed detection products in Australia and a $50 million investment from a Global Fortune 500 tech firm, further boost its credibility and growth potential.
The company is also advancing development with a Top 10 global automotive OEM, with Atlas Ultra slated for future integration into production vehicles, potentially unlocking mass scale deployment.
However, risks remain. Aeva is still unprofitable and will likely require additional capital to scale manufacturing and R&D. Its success hinges on transitioning from development contracts to volume production.
But with its proprietary FMCW technology, strong IP, and deepening industry ties, Aeva Technologies Inc (NASDAQ:AEVA) is fast becoming one of the most compelling LiDAR stocks to watch in 2025.
02. Bitmine Immersion Technologies Inc (NYSE:BMNR) : High Return Crypto Infrastructure Play in the US Stock Market
Year to date Price Return as of July 8: 1329.49%
At number two spot on our list of best performing US stocks of 2025 stands Bitmine Immersion Technologies Inc (NYSE:BMNR). It is quietly making waves in the booming crypto infrastructure space, and investors are paying attention. With revenue growth accelerating and new strategic lease agreements locking in millions, this under the radar stock is positioning itself as a breakout blockchain infrastructure play in 2025.
Headquartered in Las Vegas, Bitmine Immersion Technologies Inc (NYSE:BMNR) operates as a diversified crypto technology company. Its core operations span self mining Bitcoin, equipment leasing, data center hosting, and mining equipment sales. Bitmine also offers infrastructure services including power, cooling, and security solutions, all essential to large scale crypto mining operations.
For the nine months ended May 31, 2025, Bitmine Immersion Technologies Inc (NYSE:BMNR) nearly doubled its revenue to $4.77 million, up from $2.63 million in the same period in 2024. While Bitcoin mining revenue rose 18% year over year, the company strategically shifted toward leasing out mining capacity, locking in $4 million in lease deals that guarantee predictable revenue through year end, even if Bitcoin prices fluctuate.
Bitmine also recorded $846,347 in equipment sales, an impressive 4x jump from the prior year. It’s expanding its “buy/host” model, selling miners already installed in their facilities, unlocking additional monetization streams. Meanwhile, consulting services brought in $35,000 this quarter from a single high value contract.
However, profitability remains a challenge. Net loss stood at $622,762 for Q2, driven by rising operational costs and stock based compensation. The company also faces long term risks from volatile energy prices, Bitcoin price swings, and regulatory uncertainty.
Still, with robust infrastructure, steady leasing cash flow, and operational diversification, Bitmine Immersion Technologies Inc (NYSE:BMNR) is building a more resilient crypto business model. For investors seeking exposure to the infrastructure backbone of Bitcoin mining, not just the coin itself, Bitmine Immersion Technologies Inc (NYSE:BMNR) offers a compelling, high upside opportunity in 2025.
01. DeFi Development Corp (NASDAQ:DFDV) : The Best Performing US Stock of 2025 With Over 2,800% YTD Return
Year to date Price Return as of July 8: 2830.43%
Topping our list of ten best performing US stocks in 2025 is DeFi Development Corp (NASDAQ:DFDV). It is one of the best performing U.S. stocks, gaining more than 2,800% since January 2025. This isn’t just hype, DFDV is giving investors unique, high growth exposure to the Solana blockchain, and it’s doing so with real strategy and structure.
The company started as a real estate lending tech firm (formerly Janover Inc.), but in April 2025, it pivoted into crypto after a change in leadership. Since then, DFDV has focused on building a strong position in the Solana ecosystem. It now holds over 621,000 SOL tokens, operates validators that generate staking income, and is the first U.S. listed company to tokenize its stock on the Solana blockchain (DFDVx).
From a financial standpoint, DFDV raised $191 million, including a recent $112.5 million convertible debt deal, all aimed at buying more SOL and growing staking rewards. The company’s SOL per share (SPS) is 0.0421, and its new metrics show that, at the current rate, it could close the gap between its NAV and share price in just 55 days.
What really sets DFDV apart is how deeply it’s integrated with Solana projects. It has partnered with platforms like Sanctum, Kamino, Drift, Orca, and others to increase utility for its assets and boost returns. These connections help DFDV grow faster than most crypto ETFs or traditional funds.
Risks? Sure, SOL prices can be volatile, regulatory hurdles are real, and dilution from convertible securities is a concern. But DFDV’s focus on long term value, smart capital raising, and transparency makes it a bold bet for investors looking for cutting edge blockchain exposure.
With strong fundamentals and growing visibility, DeFi Development Corp (NASDAQ:DFDV) is easily one of the best performing US stocks of 2025, and it’s just getting started.
Frequently Asked Questions
What are the best performing US stocks in 2025?
As of July 2025, DeFi Development Corp, Bitmine Immersion, and Aeva Technologies, BioSig Technologies Inc, ThredUp Inc, Arena Group Holdings Inc, Vigil Neuroscience Inc, Sezzle Inc, CoreWeave Inc and Citius Oncology Inc are among the top performers.
Read Next:
- 7 Best Real Estate Stocks To Buy Now
- 7 High Dividend Tech Stocks to Buy for Long Term Growth in 2025
Disclaimer: None. The article is originally published on TheRichStocks.com.
